Local News Chinook Therapeutics Raises $106M As It Prepares to Merge with Aduro BiotechGeekWire | August 25, 2020Chinook Therapeutics, a biotech company creating targeted therapies for kidney diseases, raised an additional $106…eabramovichAugust 25, 2020 Read More
Local News Cancer Drug Synergizes with Radiation Therapy in Treatment-Resistant Prostate CancerCanada's Michael Smith Genome Sciences Centre at BC Cancer | August 25, 2020For some prostate cancer patients, radiation and androgen deprivation therapy—a type of chemotherapy that reduces…eabramovichAugust 25, 2020 Read More
Local News AbCellera Acquires OrthoMab Bispecific Platform to Propel the Development of Antibody Therapies for Pharma and Biotech PartnersAbCellera | August 24, 2020AbCellera today announced the acquisition of the OrthoMab bispecific platform from Dualogics, LLC. (Dualogics). OrthoMab…eabramovichAugust 24, 2020 Read More
Local News New Study Helps Improve Bespoke Immune Cells’ Ability to Prevent Transplant Rejection in Patients with Donated TissueBC Children's Hospital Research Institute | August 24, 2020A new study, published this week in Science Translational Medicine, further refines a potential new treatment…eabramovichAugust 24, 2020 Read More
Local News Marathon of Hope Cancer Centres Network Operational Plan Continues to Take ShapeTerry Fox Research Institute | August 21, 2020Plans for implementation of the new pan-Canadian network to accelerate precision medicine continue to move…eabramovichAugust 21, 2020 Read More
Local News Fast and Furious: Targeting “Nitro(gen) Boosts” in a Deadly Bacterium for Next-Generation AntimicrobialsCentre for Blood Research | August 21, 2020In Fast and Furious, one of the greatest films of all time, Paul Walker almost wins…eabramovichAugust 21, 2020 Read More
Local News Biotech Coalition Hopes Llama Nanobodies Hold Key to COVID-19 TreatmentCBC News | August 20, 2020A coalition of Canadian biotech companies are hoping that fragments of antibodies they've raised and sequenced…eabramovichAugust 20, 2020 Read More
Local News Qu Biologics Initiates Phase 2 Study to Assess Activation of Anti-Cancer Immune Response in Colon CancerLifeSciences BC | August 20, 2020Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed…eabramovichAugust 20, 2020 Read More
Local News Researchers Identify Mutation Associated with Improved Survival in Diffuse Large B-Cell LymphomaTerry Fox Research Institute | August 19, 2020In a paper published in Nature Medicine (April 2020), the team led by Drs. David Scott and…sciencecityAugust 19, 2020 Read More
Local News Fast and Loose: Nanomachines with Floppy Connections Go FasterSFU News | August 19, 2020Converting energy quickly and efficiently is critical to both human-engineered machinery, and to the microscopic…sciencecityAugust 19, 2020 Read More